Abbott s new global diagnostics coalition focuses on future pandemic preparedness
Abbott s new global diagnostics coalition focuses on future pandemic preparedness
Kelsy Ketchum, 360Dx
Print
Although the pandemic isn t over yet, the question of future pandemics is still on the mind of many infectious disease experts.
With that in mind, Abbott is using its infectious disease experience, building on its Global Viral Surveillance Program for HIV and viral hepatitis research, to spearhead a coalition that will prepare for disease outbreaks, particularly those that haven t yet happened and pathogens that have yet to be discovered.
According to Gavin Cloherty, the head of infectious disease research at Abbott, the Abbott Pandemic Defense Coalition is the culmination of several years of preparation that has grown from the global surveillance program.
Abbott Pandemic Defence Coalition aims to identify new viral threats and take quick action
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Abbott has announced its Pandemic Defense Coalition
selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.
Operator
Ladies and gentlemen, thank you for standing by, and welcome to Labcorp Fourth Quarter 2020 Earnings Conference Call. [Operator Instructions]
It is now my pleasure to introduce Vice President of Investor Relations, Clarissa Willett.
Clarissa Willett
Vice President, Investor Relations
Thank you, operator. Good morning and welcome to Labcorp s Fourth Quarter 2020 Conference Call. As detailed in today s press release, there will be a replay of this conference call available via telephone and Internet. With me today are Adam Schechter, Chairman and Chief Executive Officer; and Glenn Eisenberg, Executive Vice President and Chief Financial Officer.
This morning, in the Investor Relations section of our website, we posted both our press release and an Investor Relations presentation with additional information on our business and operations, which include a reconciliation of the non-GAAP financial measures to the GAAP financial measures discussed during today s call. Addit
Chris Crank and Mark Glasper Named to Board of Governors of the Pharmacy Technician Certification Board (PTCB)
News provided by
Share this article
Share this article
WASHINGTON, Jan. 25, 2021 /PRNewswire/ The Pharmacy Technician Certification Board (PTCB), the leading credentialing organization for pharmacy technicians, has named Christopher W. Crank, PharmD, MS, BCPS, and Mark Glasper to the PTCB Board of Governors, effective January 1 and January 18, respectively.
Chris Crank; Mark Glasper As the new year begins, we are pleased to welcome Chris and Mark as new members of our Board of Governors, said William Schimmel, PTCB Executive Director and CEO. They ve hit the ground running. With their combined organizational leadership experience, they will help move PTCB forward on our trajectory toward advancing medication safety by credentialing qualified technicians who enable pharmacy teams to perform at their highest levels.